Table 1.

Clinicopathological information about experimental glioblastoma patients involved in this study.

Sample ID	Gender	Age at Diagnosis	KPS	WHO Grade	Recurrent Tumor	OS (Months)	IDH1 R132H Mutation	ATRX Loss	p53	MGMT Methylation	GTR	Therapy	Adjuvant Therapy	TTP (Months)
NB-00131/12	M	42	90	IV	No	13	Negative	Not performed	Negative	No	No	60 Gy radiotherapy + TMZ	Adjuvant TMZ	/
NB-00094/13	M	47	90	IV	No	16	Negative	Not performed	Positive	Yes	Yes	60 Gy radiotherapy + TMZ	Adjuvant TMZ	10
17-H-21518	M	64	100	IV	No	16	Negative	No	Negative	No	Yes	60 Gy radiotherapy + TMZ	Adjuvant TMZ	8
NB-00233/12	F	42	100	IV	No	18	Negative	Not performed	Negative	No	Yes	60 Gy radiotherapy + TMZ	No (TMZ side effects)	6
NB-00464/12	M	62	90	IV	No	19	Not performed	Not performed	Not performed	No	No	30 Gy radiotherapy + TMZ	Adjuvant TMZ	14
NB-00079/14	M	43	90	IV	No	20	Positive	Not performed	Positive	No	Yes	60 Gy radiotherapy + TMZ	Adjuvant TMZ	15
17-H-05191	M	68	100	IV	No	21	Negative	No	Positive	No	Yes	60 Gy radiotherapy + TMZ	Adjuvant TMZ	12
16-H-17976	M	66	70	IV	No	23	Negative	No	Negative	Yes	Yes	60 Gy radiotherapy + TMZ	Adjuvant TMZ	16
NB-00173/14	M	55	90	IV	No	26	Negative	Not performed	Negative	Yes	Yes	60 Gy radiotherapy + TMZ	Adjuvant TMZ	21
NB-00369/13	F	62	90	IV	No	31	Negative	Not performed	Positive	No	Yes	60 Gy radiotherapy + TMZ	Adjuvant TMZ	26
NB-00450/12	F	58	80	IV	No	50	Negative	Not performed	Negative	Yes	No	60 Gy radiotherapy + TMZ	Adjuvant TMZ	37
NB-00038/13	F	61	80	IV	No	58	Negative	Not performed	Positive	No	Yes	60 Gy radiotherapy + TMZ	Adjuvant TMZ	14
NB-00339/13	M	22	100	IV	No	91	Negative	Not performed	Negative	No	Yes	60 Gy radiotherapy + TMZ	Adjuvant TMZ	90 *
NB-00046/12	M	62	80	IV	No	2	Negative	Not performed	Negative	Yes	No	34 Gy radiotherapy + TMZ	No	2
NB-00003/15	F	68	70	IV	No	2	Negative	Yes	Negative	No	No	30 Gy radiotherapy	/	2
17-H-31914	M	70	50	IV	No	2	Negative	No	Negative	Yes	No	None	None	2

KPS: Karnofsky performance scale; WHO: World Health Organization; IDH1: Isocitrate dehydrogenase 1; R: Arginine; H: Histidine; ATRX: ATP-dependent helicase ATRX, X-linked helicase II; p53: Tumor protein p53; MGMT: O⁶-methylguanine DNA methyltransferase promoter methylation status; GTR: Gross total resection; TTP: Time to progression; OS: overall survival; TMZ: Temozolomide; *: Patient presented with progression after the analysis was performed.